REGINA DAY: Open Payments
NPI 1720747850 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 17 payments from 9 companies in 2025. Trend: 2023 $1,578 · 2024 $1,014 · 2025 $579
Food & beverage: $471Education: $108
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $192 |
| Janssen Biotech, Inc. | 5 | $189 |
| Regeneron Healthcare Solutions, Inc. | 3 | $90 |
| ABBVIE INC. | 2 | $37 |
| Incyte Corporation | 1 | $15 |
| Galderma Laboratories, L.P. | 1 | $14 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $14 |
| Amgen Inc. | 1 | $14 |
| Janssen Pharmaceuticals, Inc | 1 | $13 |
Products named: TREMFYA, Leqselvi, DUPIXENT, SKYRIZI, ILUMYA, OPZELURA, NEMLUVIO, VALCHLOR.
Industry payments across PA — which companies pay providers there.
